was read the article
array:26 [ "pii" => "S2174204918303805" "issn" => "21742049" "doi" => "10.1016/j.repce.2018.02.020" "estado" => "S300" "fechaPublicacion" => "2018-11-01" "aid" => "1236" "copyright" => "Sociedade Portuguesa de Cardiologia" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2018;37:889-97" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1519 "formatos" => array:3 [ "EPUB" => 103 "HTML" => 1134 "PDF" => 282 ] ] "Traduccion" => array:1 [ "pt" => array:20 [ "pii" => "S0870255117307485" "issn" => "08702551" "doi" => "10.1016/j.repc.2018.02.008" "estado" => "S300" "fechaPublicacion" => "2018-11-01" "aid" => "1236" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2018;37:889-97" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2491 "formatos" => array:3 [ "EPUB" => 87 "HTML" => 2073 "PDF" => 331 ] ] "pt" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>" "titulo" => "<span class="elsevierStyleItalic">Score</span> CRUSADE – Será ainda um bom <span class="elsevierStyleItalic">score</span> para prever a hemorragia na síndrome coronária aguda?" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => array:2 [ 0 => "pt" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "889" "paginaFinal" => "897" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "CRUSADE: Is it still a good score to predict bleeding in acute coronary syndrome?" ] ] "contieneResumen" => array:2 [ "pt" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1451 "Ancho" => 1453 "Tamanyo" => 78846 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Curva <span class="elsevierStyleItalic">Receiver Operating Characteristic</span> (ROC) do <span class="elsevierStyleItalic">score</span> CRUSADE na predição de hemorragia <span class="elsevierStyleItalic">major</span> na nossa população.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Dina Bento, Nuno Marques, Pedro Azevedo, João Guedes, João Bispo, Daniela Silva, José Amado, Walter Santos, Jorge Mimoso, Ilídio de Jesus" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Dina" "apellidos" => "Bento" ] 1 => array:2 [ "nombre" => "Nuno" "apellidos" => "Marques" ] 2 => array:2 [ "nombre" => "Pedro" "apellidos" => "Azevedo" ] 3 => array:2 [ "nombre" => "João" "apellidos" => "Guedes" ] 4 => array:2 [ "nombre" => "João" "apellidos" => "Bispo" ] 5 => array:2 [ "nombre" => "Daniela" "apellidos" => "Silva" ] 6 => array:2 [ "nombre" => "José" "apellidos" => "Amado" ] 7 => array:2 [ "nombre" => "Walter" "apellidos" => "Santos" ] 8 => array:2 [ "nombre" => "Jorge" "apellidos" => "Mimoso" ] 9 => array:2 [ "nombre" => "Ilídio de" "apellidos" => "Jesus" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204918303805" "doi" => "10.1016/j.repce.2018.02.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204918303805?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255117307485?idApp=UINPBA00004E" "url" => "/08702551/0000003700000011/v4_201911280953/S0870255117307485/v4_201911280953/pt/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2174204918303878" "issn" => "21742049" "doi" => "10.1016/j.repce.2018.12.002" "estado" => "S300" "fechaPublicacion" => "2018-11-01" "aid" => "1317" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "dis" "cita" => "Rev Port Cardiol. 2018;37:899-900" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 717 "formatos" => array:3 [ "EPUB" => 72 "HTML" => 413 "PDF" => 232 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial comment</span>" "titulo" => "The CRUSADE score and bleeding in acute coronary syndrome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "899" "paginaFinal" => "900" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "<span class="elsevierStyleItalic">Score</span> CRUSADE e a hemorragia na Síndrome Coronária Aguda" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jorge Mimoso" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jorge" "apellidos" => "Mimoso" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204918303878?idApp=UINPBA00004E" "url" => "/21742049/0000003700000011/v1_201812150634/S2174204918303878/v1_201812150634/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2174204918303829" "issn" => "21742049" "doi" => "10.1016/j.repce.2018.10.007" "estado" => "S300" "fechaPublicacion" => "2018-11-01" "aid" => "1283" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "dis" "cita" => "Rev Port Cardiol. 2018;37:885-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 530 "formatos" => array:3 [ "EPUB" => 94 "HTML" => 248 "PDF" => 188 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial comment</span>" "titulo" => "Cardiac computed tomography for atrial fibrillation ablation – a one-stop shop?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "885" "paginaFinal" => "887" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "TC cardíaca na ablação da fibrilhação auricular – <span class="elsevierStyleItalic">one-stop-shop</span>?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana G. Almeida" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Ana G." "apellidos" => "Almeida" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S0870255118304979" "doi" => "10.1016/j.repc.2018.07.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255118304979?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204918303829?idApp=UINPBA00004E" "url" => "/21742049/0000003700000011/v1_201812150634/S2174204918303829/v1_201812150634/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S2174204918303878" "issn" => "21742049" "doi" => "10.1016/j.repce.2018.12.002" "estado" => "S300" "fechaPublicacion" => "2018-11-01" "aid" => "1317" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "dis" "cita" => "Rev Port Cardiol. 2018;37:899-900" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 717 "formatos" => array:3 [ "EPUB" => 72 "HTML" => 413 "PDF" => 232 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial comment</span>" "titulo" => "The CRUSADE score and bleeding in acute coronary syndrome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "899" "paginaFinal" => "900" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "<span class="elsevierStyleItalic">Score</span> CRUSADE e a hemorragia na Síndrome Coronária Aguda" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jorge Mimoso" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jorge" "apellidos" => "Mimoso" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204918303878?idApp=UINPBA00004E" "url" => "/21742049/0000003700000011/v1_201812150634/S2174204918303878/v1_201812150634/en/main.assets" ] ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "CRUSADE: Is it still a good score to predict bleeding in acute coronary syndrome?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "889" "paginaFinal" => "897" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Dina Bento, Nuno Marques, Pedro Azevedo, João Guedes, João Bispo, Daniela Silva, José Amado, Walter Santos, Jorge Mimoso, Ilídio de Jesus" "autores" => array:10 [ 0 => array:4 [ "nombre" => "Dina" "apellidos" => "Bento" "email" => array:1 [ 0 => "dinabento@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Nuno" "apellidos" => "Marques" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Pedro" "apellidos" => "Azevedo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "João" "apellidos" => "Guedes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "João" "apellidos" => "Bispo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "Daniela" "apellidos" => "Silva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 6 => array:3 [ "nombre" => "José" "apellidos" => "Amado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "Walter" "apellidos" => "Santos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 8 => array:3 [ "nombre" => "Jorge" "apellidos" => "Mimoso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 9 => array:3 [ "nombre" => "Ilídio" "apellidos" => "de Jesus" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Serviço de Cardiologia, Centro Hospitalar Universitário do Algarve, Faro, Portugal" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Algarve Biomedical Center, Faro, Portugal" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "<span class="elsevierStyleItalic">Score</span> CRUSADE – Será ainda um bom <span class="elsevierStyleItalic">score</span> para prever a hemorragia na síndrome coronária aguda?" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1386 "Ancho" => 1453 "Tamanyo" => 74919 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Receiver operating characteristic curve of the CRUSADE score for predicting in-hospital major bleeding in our population.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Introduction</span><p id="par0060" class="elsevierStylePara elsevierViewall">Patients with acute coronary syndrome (ACS) are a heterogeneous population, with varying levels of risk for events, and so initial assessment has a crucial role in deciding the most appropriate therapeutic strategy.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">1</span></a> Treatment of these patients includes antithrombotic therapy and invasive procedures, which carry an increased risk of bleeding,<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">2</span></a> the incidence of which ranges between 1% and 10%.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">3</span></a> This variability in the incidence of bleeding complications is due to various factors, including differences in patient characteristics, concomitant treatment and definitions of bleeding.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">3</span></a> Nevertheless, whatever definition is used, multiple studies have shown that bleeding complications are associated with adverse events including death, non-fatal myocardial infarction (MI), stroke, and stent thrombosis.<a class="elsevierStyleCrossRefs" href="#bib0225"><span class="elsevierStyleSup">3–5</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">Assessment of the risk of bleeding includes a detailed history of bleeding symptoms, identification of predisposing comorbidities, laboratory data, and calculation of a bleeding risk score.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">6</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">The CRUSADE score<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">7</span></a> was developed to assess bleeding risk based on a varied population of patients with non-ST-elevation ACS (NSTE-ACS), and was subsequently validated for ST-elevation myocardial infarction (STEMI).<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">8</span></a> It is calculated from eight variables that include baseline characteristics, clinical variables and admission laboratory values.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">7</span></a> It is currently the most commonly used score to determine bleeding risk, due to its proven discriminatory power.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">6,9,10</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">The main purpose of the CRUSADE score is to stratify bleeding risk in patients with ACS, in order to select appropriate therapeutic strategies that will reduce bleeding events and hence improve prognosis.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">9</span></a></p><p id="par0080" class="elsevierStylePara elsevierViewall">The aim of this study is to analyze the applicability of the CRUSADE score in ACS patients, in light of the significant changes that have taken place over the last decade in the management and treatment of these patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Study design</span><p id="par0085" class="elsevierStylePara elsevierViewall">This was a retrospective, descriptive, correlational study of patients admitted with a diagnosis of ACS to the cardiology department of Centro Hospitalar Universitário do Algarve between October 1, 2010 and August 31, 2014. The CRUSADE score was calculated for each patient and its ability to predict in-hospital major bleeding (IHMB) was assessed. Predictors of IHMB were determined.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Patient selection</span><p id="par0090" class="elsevierStylePara elsevierViewall">A total of 2818 patients diagnosed with ACS in the previous 48 hours were included. MI was diagnosed in the presence of chest pain or anginal equivalent in the previous 48 hours together with ischemic electrocardiographic changes (ST-segment deviation or negative T waves) and elevation of troponin levels above the reference value. Unstable angina was defined as the presence of chest pain or anginal equivalent with or without with ischemic electrocardiographic changes in the absence of elevation of troponin levels above the reference value.</p><p id="par0095" class="elsevierStylePara elsevierViewall">Patients with MI associated with revascularization procedures (types 4 and 5) or type 2 MI according to the ESC/ACCF/AHA/WHF universal definition of myocardial infarction<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">11</span></a> were excluded.</p><p id="par0100" class="elsevierStylePara elsevierViewall">In the analysis of the predictive ability of the CRUSADE score, 203 of the 2818 patients (7.2%) were excluded due to inability to calculate the score.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Data collection</span><p id="par0105" class="elsevierStylePara elsevierViewall">Data were collected on demographics (age and gender), relevant personal history (MI, heart failure, percutaneous coronary intervention [PCI], coronary artery bypass graft surgery, chronic obstructive pulmonary disease [COPD] and cancer), and cardiovascular risk factors (hypertension, diabetes, dyslipidemia and smoking status). Data were also analyzed on hospital stay, including clinical parameters at admission (systolic blood pressure, heart rate and hematocrit), coronary angiography (vascular access and PCI), left ventricular ejection fraction (LVEF), type of ACS (STEMI, non-ST-segment MI [NSTEMI], MI of undetermined location, or unstable angina), and medication (aspirin, clopidogrel, ticagrelor, enoxaparin, unfractionated heparin, warfarin, and glycoprotein [GP] IIb/IIIa inhibitors).</p><p id="par0110" class="elsevierStylePara elsevierViewall">Creatinine clearance was estimated by the Cockcroft-Gault formula.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">12</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">Vascular disease was identified on the basis of a history of peripheral arterial disease and/or stroke.</p><p id="par0120" class="elsevierStylePara elsevierViewall">In-hospital mortality was defined as death from any cause during hospitalization for ACS.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Study objectives</span><p id="par0125" class="elsevierStylePara elsevierViewall">The study objectives were assessment of the predictive ability of the CRUSADE score for in-hospital major bleeding (IHMB) and determination of independent predictors of IHMB.</p><p id="par0130" class="elsevierStylePara elsevierViewall">IHMB was defined according to the GUSTO classification as intracerebral bleeding or bleeding resulting in hemodynamic compromise requiring treatment.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">13</span></a> The CRUSADE score was calculated from eight variables (baseline hematocrit, estimated creatinine clearance, baseline heart rate, baseline systolic blood pressure, gender, signs of heart failure on presentation, prior vascular disease, and diabetes). The five bleeding risk categories defined by the CRUSADE investigators were used: very low risk (score ≤20), low risk (21-30), moderate risk (31-40), high risk (41-50), and very high risk (>50).</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Statistical analysis</span><p id="par0135" class="elsevierStylePara elsevierViewall">A descriptive analysis was performed to characterize the study sample. Continuous variables are presented as mean ± standard deviation and categorical variables as number (percentage).</p><p id="par0140" class="elsevierStylePara elsevierViewall">The predictive ability of the CRUSADE score in our population was tested using the area under the curve (AUC) on receiver operating characteristic analysis<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">14</span></a> and the model's goodness of fit was assessed by the Hosmer-Lemeshow test,<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">15</span></a> in which adequate goodness of fit is indicated by a non-significant p value.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Associations between categorical variables were analyzed using the chi-square test and continuous variables using the Student's t test.</p><p id="par0150" class="elsevierStylePara elsevierViewall">Binary logistic regression analysis was used to determine predictors of IHMB. A p-value of <0.05 was considered to indicate a 95% significance level. IBM SPSS Statistics (version 20.0) was used for the statistical analysis.</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Results</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Population characteristics</span><p id="par0155" class="elsevierStylePara elsevierViewall">The baseline characteristics of the study population are presented in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0160" class="elsevierStylePara elsevierViewall">A total of 2818 ACS patients were included, 73.9% male, mean age 66±13 years. At admission, mean hematocrit was 41±5%, mean heart rate was 77±18 bpm, mean systolic blood pressure was 139±30 mmHg, mean creatinine clearance was 81±37 ml/min, and 10.9% presented signs of heart failure.</p><p id="par0165" class="elsevierStylePara elsevierViewall">The most frequent diagnosis at admission was NSTEMI (48.4%), followed by STEMI (44.4%). Coronary angiography was performed in 75.3% of patients (91.5% by radial access), and 58.3% underwent PCI.</p><p id="par0170" class="elsevierStylePara elsevierViewall">With regard to antithrombotic therapy during hospitalization, 96.8% of the patients received aspirin, 73% clopidogrel, 2.8% ticagrelor and 47.9% fondaparinux.</p><p id="par0175" class="elsevierStylePara elsevierViewall">During hospital stay, 113 (4.0%) patients died and 52 (1.8%) presented IHMB.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Discriminatory power of the CRUSADE score</span><p id="par0180" class="elsevierStylePara elsevierViewall">The rate of IHMB predicted in the study population was 7.1%, while the observed rate was 1.8%, a statistically significant difference (p<0.001) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0185" class="elsevierStylePara elsevierViewall">The incidence of IHMB in the different categories of the CRUSADE score was 0.5% in the very low risk category (rate predicted by the score 3.1%), 1.5% in the low risk category (5.5%), 1.6% in the moderate risk category (8.6%), 5.5% in the high risk category (11.9%), and 4.4% in the high risk category (19.5%) (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>).</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0190" class="elsevierStylePara elsevierViewall">The predictive ability of the CRUSADE score in the study population was moderate, with an AUC of 0.73 (<a class="elsevierStyleCrossRef" href="#fig0005">Figure 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Predictors of in-hospital major bleeding</span><p id="par0195" class="elsevierStylePara elsevierViewall">The occurrence of IHMB was associated with the following variables: advanced age (p=0.01), hypertension (p=0.029), angina (p=0.01), previous bleeding (p<0.001), COPD (p=0.021), cancer (p<0.001), higher baseline heart rate (p<0.001), lower hemoglobin (p=0.005), femoral access (p<0.001), and lower LVEF at discharge (p<0.001). IHMB was also associated with higher in-hospital mortality (15.4% vs. 3.8%; p<0.001) (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0200" class="elsevierStylePara elsevierViewall">When the above significant associations were included in multivariate analysis, advanced age (p=0.027), femoral access (p=0.004), higher heart rate (p=0.047) and medication with ticagrelor during hospital stay (p=0.027) were identified as independent predictors of IHMB (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>).</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Discussion</span><p id="par0205" class="elsevierStylePara elsevierViewall">In this contemporary population of patients with ACS, the CRUSADE score overestimated the risk of IHMB.</p><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">In-hospital major bleeding</span><p id="par0210" class="elsevierStylePara elsevierViewall">The incidence of IHMB in the literature is 1-10%; this variability is due to various factors including differences in patient characteristics, concomitant therapy and definitions of bleeding.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">3</span></a></p><p id="par0215" class="elsevierStylePara elsevierViewall">The rate of IHMB in our study was 1.8%. This is significantly lower than that predicted by the CRUSADE score (7.1%) (p<0.001). The CRUSADE score overestimated bleeding risk in all risk categories, with greater differences in higher risk categories (moderate, high and very high).</p><p id="par0220" class="elsevierStylePara elsevierViewall">These findings may be explained by evidence that the rate of IHMB in patients with ACS has decreased over time, despite the use of more aggressive drug therapies and interventions. Fox et al. reported a significant fall in bleeding rates in patients with ACS between 2000 and 2007, from 2.6% to 1.8% (p<0.001).<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">16</span></a> Factors contributing to this decrease include improvements in cardiac catheterization techniques, the introduction of smaller catheters, the use of radial access, better selection of antithrombotic therapy and changes to thresholds for red blood cell transfusion.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">16</span></a></p><p id="par0225" class="elsevierStylePara elsevierViewall">Patients with IHMB have a worse prognosis, with greater risk for in-hospital mortality.<a class="elsevierStyleCrossRefs" href="#bib0290"><span class="elsevierStyleSup">16,17</span></a> In a study by Spencer et al. of 40<span class="elsevierStyleHsp" style=""></span>087 patients with MI, IHMB was associated with greater mortality (21% vs. 6%, p<0.001).<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">17</span></a> IHMB was also associated with higher mortality in our study (15.4% vs. 3.8%, p<0.001). Measures must be taken to reduce the negative impact of IHMB on prognosis in ACS. However, several risk factors for bleeding are also predictors of ischemic events, complicating the task of maximizing anti-ischemic effectiveness while minimizing bleeding risk.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">7,10</span></a></p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Discriminatory power of the CRUSADE score</span><p id="par0230" class="elsevierStylePara elsevierViewall">The ability of the CRUSADE score to predict IHMB in our population was acceptable, with an AUC of 0.73. However, this is hardly an optimal result. In a cohort of 4500 patients with ACS, Abu-Assi et al. assessed the performance of the CRUSADE score, finding a c-statistic of 0.80 for predicting major bleeding events,<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">9</span></a> and similarly, Manzano-Fernández et al. calculated an AUC of 0.79 in a study of 1587 patients with ACS.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">1</span></a> However, other studies have reported lower figures: the AUC was 0.70 in a study of 1976 patients with ACS by Ariza-Solé et al.,<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">18</span></a> while Amador et al. found an AUC of 0.61 in their population of 516 ACS patients.<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">19</span></a> The CRUSADE score has been shown to have poor predictive ability, with AUC values below 0.70, in certain subgroups, including those aged over 75 years, those who have not undergone coronary angiography, and those not receiving anticoagulant therapy.<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">9,20,21</span></a> Its performance was actually rather modest (AUC 0.68) in the population in which the score was developed.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">7</span></a></p><p id="par0235" class="elsevierStylePara elsevierViewall">There is thus considerable variability in the discriminatory power of the CRUSADE score in ACS patients. This may be due to a range of factors that hinder assessment of bleeding risk, including age, comorbidities, antithrombotic therapy, choice of strategy (invasive or conservative), and site of vascular access for angiography. There is a need for a score that is suitable for current clinical practice and that can provide accurate, individualized and simple bleeding risk stratification in patients with ACS.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Predictors of in-hospital major bleeding</span><p id="par0240" class="elsevierStylePara elsevierViewall">The independent predictors of IHMB identified in our study were advanced age, higher heart rate on admission, femoral access and medication with ticagrelor during hospital stay.</p><p id="par0245" class="elsevierStylePara elsevierViewall">As pointed out above, patients with ACS are a heterogeneous population, which means that different predictors of major bleeding will be found in different patient populations. A study by Mehran et al. in 17<span class="elsevierStyleHsp" style=""></span>421 patients with ACS identified seven predictors of bleeding, including female gender, advanced age, elevated serum creatinine, white cell count, anemia and use of unfractionated heparin plus a GP IIb/IIIa inhibitor.<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">22</span></a> Moscucci et al. determined female gender, advanced age, renal insufficiency and history of bleeding as independent predictors of bleeding among 24<span class="elsevierStyleHsp" style=""></span>045 ACS patients in the GRACE registry.<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">23</span></a> As well as age, female gender and renal insufficiency, Nikolsky et al. identified pre-existing anemia, administration of low molecular weight heparin within 48 hours pre-PCI, and use of intra-aortic balloon pump as predictors of major bleeding.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">24</span></a> Although there are differences between these studies in the incidence and definition of bleeding, age, female gender and renal failure are frequently identified variables.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">2,22,23</span></a> In our study, ticagrelor use was a predictor of IHMB, although it should be borne in mind that only 2.8% of our population were taking the drug. In the PLATO trial, compared to clopidogrel, treatment with ticagrelor reduced vascular mortality, MI and stroke, but was associated with a higher rate of bleeding not related to coronary artery bypass graft surgery (4.5% vs. 3.8%; p=0.03).<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">25</span></a></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Vascular access for coronary angiography</span><p id="par0250" class="elsevierStylePara elsevierViewall">In our study, 91.5% of patients underwent angiography via radial access, a higher proportion than in other studies assessing the applicability of the CRUSADE score, which reported rates between 64% and 83.1%.<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">1,9,18,26</span></a> In multivariate analysis, femoral access was an independent predictor of IHMB (p=0.004), which is in line with recent clinical evidence.<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">27,28</span></a> However, when interpreting this result it should be borne in mind that femoral access was used in only 8.5% of patients.</p><p id="par0255" class="elsevierStylePara elsevierViewall">Periprocedural major bleeding is a complication that can affect patients undergoing PCI, with an incidence of 1.7-3.5% in recent studies.<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">29–31</span></a> Multiple studies have shown that radial access is associated with lower rates of periprocedural bleeding than femoral access.<a class="elsevierStyleCrossRefs" href="#bib0370"><span class="elsevierStyleSup">32–35</span></a></p><p id="par0260" class="elsevierStylePara elsevierViewall">The RIVAL trial reported a lower rate of major vascular complications for radial access in patients with ACS (1.4% vs. 3.7%; p<0.0001).<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">35</span></a> However, results for mortality were inconsistent, with lower mortality in patients with STEMI but not in those with non-ST-elevation ACS (NSTE-ACS). In the MATRIX trial, radial access reduced bleeding complications and overall mortality in patients with ACS (STEMI and NSTEMI) compared to femoral access.<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">27</span></a> In the European guidelines the use of radial access is a class I recommendation, level of evidence A.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">10</span></a></p><p id="par0265" class="elsevierStylePara elsevierViewall">The high rate of radial access in our study may have contributed to the low rate of IHMB in our population. The fact that access type is not included in its parameters constitutes a limitation of the CRUSADE score.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">Fondaparinux</span><p id="par0270" class="elsevierStylePara elsevierViewall">Regarding anticoagulation, fondaparinux was used in 47.9% of our population, considerably more than enoxaparin (16.6%).</p><p id="par0275" class="elsevierStylePara elsevierViewall">In the OASIS-5 trial in patients with NSTE-ACS, fondaparinux significantly reduced major bleeding events compared to enoxaparin (p<0.001).<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">36</span></a> Fondaparinux is the parenteral anticoagulant recommended in the current guidelines for NSTE-ACS patients, due to its safety and efficacy profile.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">10</span></a> Despite this recommendation, rates of fondaparinux use in other series are lower than in ours (1.6-14%).<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">1,9,37</span></a></p><p id="par0280" class="elsevierStylePara elsevierViewall">We believe that the use of this anticoagulant in our population may also have contributed to the low rate of IHMB.</p></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">Glycoprotein IIb/IIIa inhibitors and P2Y<span class="elsevierStyleInf">12</span> receptor inhibitors</span><p id="par0285" class="elsevierStylePara elsevierViewall">GP IIb/IIIa inhibitors were used in 49% of our population, a higher rate than in other series (5.7-40.2%).<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">1,9,18,19,37</span></a> It should, however, be noted that in most cases this consisted only of the administration of a bolus of eptifibatide during coronary angiography and that the drug was not infused after angioplasty, which may have contributed to our low rate of periprocedural bleeding complications.</p><p id="par0290" class="elsevierStylePara elsevierViewall">There is evidence that in patients with NSTE-ACS undergoing PCI, GP IIb/IIIa inhibitors reduce ischemic events, mainly reinfarction, although they also increase bleeding.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">6,38</span></a></p><p id="par0295" class="elsevierStylePara elsevierViewall">Following the HORIZONS-AMI trial, which showed that anticoagulation with bivalirudin alone was superior to heparin plus GP IIb/IIIa inhibitors in patients undergoing primary PCI, with significantly reduced 30-day rates of major bleeding and mortality,<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">39</span></a> use of GP IIb/IIIa inhibitors declined. The current European guidelines recommend GP IIb/IIIa inhibitors only for bailout or in cases of thrombotic complications (class IIa recommendation, level of evidence C).<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">10,40</span></a></p><p id="par0300" class="elsevierStylePara elsevierViewall">By contrast, the US guidelines<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">6</span></a> state that in patients with NSTE-ACS and high-risk features not adequately pretreated with clopidogrel or ticagrelor, it is useful to administer a GP IIb/IIIa inhibitor (class I recommendation, level of evidence A), and in NSTE-ACS patients treated with unfractionated heparin and adequately pretreated with clopidogrel, it is reasonable to administer a GP IIb/IIIa inhibitor (class IIa recommendation, level of evidence B).</p><p id="par0305" class="elsevierStylePara elsevierViewall">It should be noted that our patients preferably received a P2Y<span class="elsevierStyleInf">12</span> receptor inhibitor during or after angioplasty, which may also have contributed to the low rate of major bleeding. Current guidelines recommend pretreatment with a P2Y<span class="elsevierStyleInf">12</span> receptor inhibitor for patients with ACS.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">6,10,40</span></a> However, questions have been raised<a class="elsevierStyleCrossRefs" href="#bib0415"><span class="elsevierStyleSup">41,42</span></a> concerning pretreatment in NSTE-ACS, such as by the ACCOAST trial,<a class="elsevierStyleCrossRef" href="#bib0420"><span class="elsevierStyleSup">42</span></a> which demonstrated that pretreatment with prasugrel did not reduce the rate of ischemic events, but did increase the rate of major bleeding.</p></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0170">Clinical implications</span><p id="par0310" class="elsevierStylePara elsevierViewall">Antithrombotic therapy, which is an essential part of anti-ischemic therapy in ACS, also increases bleeding risk. Patients with ACS are a highly heterogeneous population and stratification of both ischemic and bleeding risk is needed in order to institute appropriate therapy with the desired efficacy while minimizing undesired effects.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">31</span></a> However, in the last ten years there have been significant changes in the management and treatment of ACS patients that may have altered the predictive value of risk scores.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">10</span></a> There is thus a need to develop tools to stratify bleeding risk that aim to promote strategies that reduce bleeding rates and thereby improve prognosis in these patients.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">9</span></a></p></span></span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0175">Limitations</span><p id="par0315" class="elsevierStylePara elsevierViewall">This was a single-center, retrospective, observational study, and was thus subject to the inherent biases of such studies. The low rate of bleeding events may have influenced the results, which should be validated in a larger patient cohort.</p><p id="par0320" class="elsevierStylePara elsevierViewall">The use of different definitions of major bleeding is another limitation of our study. In the CRUSADE trial, major bleeding was defined as intracranial hemorrhage, documented retroperitoneal bleed, hematocrit drop ≥12% (baseline to nadir), any red blood cell transfusion when baseline hematocrit ≥28%, or any red blood cell transfusion when baseline hematocrit <28% with witnessed bleed. In our study the GUSTO classification was used, which defines major bleeding as intracerebral bleeding or bleeding resulting in hemodynamic compromise requiring treatment.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">13</span></a></p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0180">Conclusions</span><p id="par0325" class="elsevierStylePara elsevierViewall">The IHMB rate in our study was 1.8%. The CRUSADE score, although presenting some discriminatory power, significantly overestimated the IHMB rate, especially in patients at higher risk. These results question whether the CRUSADE score should continue to be used in the stratification of bleeding risk in ACS and whether specific measures should be taken on the basis of the score result.</p></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0185">Conflicts of interest</span><p id="par0330" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres1127635" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1061238" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1127636" "titulo" => "Resumo" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introdução" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusão" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1061239" "titulo" => "Palavras-chave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Study design" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Patient selection" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Data collection" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Study objectives" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Statistical analysis" ] ] ] 6 => array:3 [ "identificador" => "sec0040" "titulo" => "Results" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Population characteristics" ] 1 => array:2 [ "identificador" => "sec0050" "titulo" => "Discriminatory power of the CRUSADE score" ] 2 => array:2 [ "identificador" => "sec0055" "titulo" => "Predictors of in-hospital major bleeding" ] ] ] 7 => array:3 [ "identificador" => "sec0060" "titulo" => "Discussion" "secciones" => array:7 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "In-hospital major bleeding" ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "Discriminatory power of the CRUSADE score" ] 2 => array:2 [ "identificador" => "sec0075" "titulo" => "Predictors of in-hospital major bleeding" ] 3 => array:2 [ "identificador" => "sec0080" "titulo" => "Vascular access for coronary angiography" ] 4 => array:2 [ "identificador" => "sec0085" "titulo" => "Fondaparinux" ] 5 => array:2 [ "identificador" => "sec0090" "titulo" => "Glycoprotein IIb/IIIa inhibitors and P2Y receptor inhibitors" ] 6 => array:2 [ "identificador" => "sec0095" "titulo" => "Clinical implications" ] ] ] 8 => array:2 [ "identificador" => "sec0100" "titulo" => "Limitations" ] 9 => array:2 [ "identificador" => "sec0105" "titulo" => "Conclusions" ] 10 => array:2 [ "identificador" => "sec0110" "titulo" => "Conflicts of interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-10-12" "fechaAceptado" => "2018-02-01" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1061238" "palabras" => array:4 [ 0 => "Major bleeding" 1 => "Acute coronary syndrome" 2 => "CRUSADE bleeding score" 3 => "In-hospital prognosis" ] ] ] "pt" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palavras-chave" "identificador" => "xpalclavsec1061239" "palabras" => array:4 [ 0 => "S<span class="elsevierStyleItalic">core</span> CRUSADE" 1 => "Síndrome coronária aguda" 2 => "Hemorragia <span class="elsevierStyleItalic">major</span>" 3 => "Prognóstico intra-hospitalar" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Major bleeding is a serious complication of acute coronary syndrome (ACS) and is associated with a worse prognosis. The CRUSADE bleeding score is used to stratify the risk of major bleeding in ACS.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To assess the predictive ability of the CRUSADE score in a contemporary ACS population.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">In a single-center retrospective study of 2818 patients admitted with ACS, the CRUSADE score was calculated for each patient and its discrimination and goodness of fit were assessed by the area under the receiver operating characteristic curve (AUC) and by the Hosmer-Lemeshow test, respectively. Predictors of in-hospital major bleeding (IHMB) were determined.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The IHMB rate was 1.8%, significantly lower than predicted by the CRUSADE score (7.1%, p<0.001). The incidence of IHMB was 0.5% in the very low risk category (rate predicted by the score 3.1%), 1.5% in the low risk category (5.5%), 1.6% in the moderate risk category (8.6%), 5.5% in the high risk category (11.9%), and 4.4% in the very high risk category (19.5%). The predictive ability of the CRUSADE score for IHMB was only moderate (AUC 0.73).</p><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">The in-hospital mortality rate was 4.0%. Advanced age (p=0.027), femoral vascular access (p=0.004), higher heart rate (p=0.047) and ticagrelor use (p=0.027) were independent predictors of IHMB.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">The CRUSADE score, although presenting some discriminatory power, significantly overestimated the IHMB rate, especially in patients at higher risk. These results question whether the CRUSADE score should continue to be used in the stratification of ACS.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] "pt" => array:3 [ "titulo" => "Resumo" "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introdução</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">A hemorragia <span class="elsevierStyleItalic">major</span> (HM) é uma complicação grave da síndrome coronária aguda (SCA) e está associada a pior prognóstico. O <span class="elsevierStyleItalic">score</span> CRUSADE permite estratificar o risco de HM na SCA.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivo</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Avaliar a capacidade preditiva do <span class="elsevierStyleItalic">score</span> CRUSADE numa população contemporânea de SCA.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Métodos</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Estudo unicêntrico e retrospetivo com 2.818 doentes admitidos por SCA. O <span class="elsevierStyleItalic">score</span> CRUSADE foi calculado para cada doente, a sua discriminação e calibração foram avaliadas pela área abaixo da curva (AUC) <span class="elsevierStyleItalic">Receiver Operating Characteristic</span> e pelo teste Hosmer-Lemeshow, respetivamente. Foram determinados os preditores de HM intra-hospitalar (HMIH).</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">A taxa de HMIH foi de 1.8%, valor significativamente inferior ao estimado pelo <span class="elsevierStyleItalic">score</span> CRUSADE (7,1%, p<0,001). A incidência de HMIH nas diferentes categorias foi de 0,5% na de muito baixo risco (taxa estimada pelo <span class="elsevierStyleItalic">score</span> de 3,1%); 1,5% na de baixo (estimada de 5,5%); 1,6% na de moderado (estimada de 8,6%); 5,5% na de elevado (estimada de 11,9%) e 4,4% na de muito elevado (estimada de 19,5%). A capacidade preditora do <span class="elsevierStyleItalic">score</span> CRUSADE para HMIH foi apenas moderada (AUC 0,73). A taxa de mortalidade intra-hospitalar foi de 4,0%. A idade mais avançada (p=0,027), o acesso vascular femoral (p=0,004), a frequência cardíaca mais elevada (p=0,047) e o ticagrelor (p=0,027) foram preditores independentes de HMIH.</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusão</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">O <span class="elsevierStyleItalic">score</span> CRUSADE, apesar de apresentar algum poder discriminatório, sobrestimou de forma significativa a taxa de HMIH, principalmente nos doentes de maior risco. Esses resultados questionam se o <span class="elsevierStyleItalic">score</span> CRUSADE deverá continuar a ser usado na estratificação da SCA.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introdução" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusão" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0035">Please cite this article as: Bento D, Marques N, Azevedo P, et al. <span class="elsevierStyleItalic">Score</span> CRUSADE – Será ainda um bom <span class="elsevierStyleItalic">score</span> para prever a hemorragia na síndrome coronária aguda? Rev Port Cardiol. 2018;37:889–897.</p>" ] ] "nomenclatura" => array:1 [ 0 => array:3 [ "identificador" => "nom0005" "titulo" => "<span class="elsevierStyleSectionTitle" id="sect0075">List of abbreviations</span>" "listaDefinicion" => array:1 [ 0 => array:1 [ "definicion" => array:11 [ 0 => array:2 [ "termino" => "ACS" "descripcion" => "<p id="par0005" class="elsevierStylePara elsevierViewall">acute coronary syndrome</p>" ] 1 => array:2 [ "termino" => "AUC" "descripcion" => "<p id="par0010" class="elsevierStylePara elsevierViewall">area under the curve</p>" ] 2 => array:2 [ "termino" => "CABG" "descripcion" => "<p id="par0015" class="elsevierStylePara elsevierViewall">coronary artery bypass grafting</p>" ] 3 => array:2 [ "termino" => "CI" "descripcion" => "<p id="par0020" class="elsevierStylePara elsevierViewall">confidence interval</p>" ] 4 => array:2 [ "termino" => "COPD" "descripcion" => "<p id="par0025" class="elsevierStylePara elsevierViewall">chronic obstructive pulmonary disease</p>" ] 5 => array:2 [ "termino" => "GP" "descripcion" => "<p id="par0030" class="elsevierStylePara elsevierViewall">glycoprotein</p>" ] 6 => array:2 [ "termino" => "IHMB" "descripcion" => "<p id="par0035" class="elsevierStylePara elsevierViewall">in-hospital major bleeding</p>" ] 7 => array:2 [ "termino" => "LVEF" "descripcion" => "<p id="par0040" class="elsevierStylePara elsevierViewall">left ventricular ejection fraction</p>" ] 8 => array:2 [ "termino" => "MI" "descripcion" => "<p id="par0045" class="elsevierStylePara elsevierViewall">myocardial infarction</p>" ] 9 => array:2 [ "termino" => "OR" "descripcion" => "<p id="par0050" class="elsevierStylePara elsevierViewall">odds ratio</p>" ] 10 => array:2 [ "termino" => "PCI" "descripcion" => "<p id="par0055" class="elsevierStylePara elsevierViewall">percutaneous coronary intervention</p>" ] ] ] ] ] ] "multimedia" => array:6 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1386 "Ancho" => 1453 "Tamanyo" => 74919 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Receiver operating characteristic curve of the CRUSADE score for predicting in-hospital major bleeding in our population.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">ACS: acute coronary syndrome; CABG: coronary artery bypass graft surgery; GP: glycoprotein; IHMB: in-hospital major bleeding; MI: myocardial infarction; NSTEMI: non-ST-elevation myocardial infarction; PCI: percutaneous coronary intervention; SBP: systolic blood pressure; STEMI: ST-elevation myocardial infarction. Data are presented as mean ± standard deviation or as percentage.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Demographic data</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Age, years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">66±13 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Male gender \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">73.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Cardiovascular risk factors</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">67.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Dyslipidemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">59.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Smoking \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">31.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Diabetes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">28.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Personal history</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Heart failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Coronary angioplasty \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">17.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>CABG \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>MI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">25.2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Vascular disease<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Bleeding \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Baseline clinical and laboratory data</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Signs of heart failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Heart rate, bpm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">77±18 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>SBP, mmHg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">139±30 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hematocrit \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">41±5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Creatinine clearance, ml/min<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">81±37 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Type of ACS</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>STEMI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">44.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>NSTEMI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">48.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>MI of undetermined location \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Unstable angina \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Coronary angiography</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">75.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Radial access \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">91.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Femoral access \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>PCI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">58.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Antithrombotic therapy</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Aspirin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">96.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Clopidogrel \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">73.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Ticagrelor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>GP IIb/IIIa inhibitors \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">49.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Fondaparinux \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Enoxaparin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Warfarin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5.1 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">IHMB</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">In-hospital mortality</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1922096.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Defined as peripheral arterial disease or previous stroke.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Estimated by the Cockcroft-Gault formula.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Baseline characteristics of the study population (n=2818).</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">IHMB: in-hospital major bleeding.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Observed, n (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Predicted by the CRUSADE score, % \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">p \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">IHMB \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 (1.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1922095.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">In-hospital major bleeding observed in the study population and predicted by the CRUSADE score.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">IHMB: in-hospital major bleeding.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Bleeding risk \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n=2615 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Observed IHMB, n (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">IHMB predicted by the CRUSADE score, % \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Very low (1-20) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">931 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (0.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.1 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Low (21-30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">681 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10 (1.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Moderate (31-40) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">509 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 (1.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">High (41-50) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">289 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16 (5.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Very high (>50) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">205 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 (4.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1922094.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">In-hospital major bleeding observed in the study population and predicted by the CRUSADE score according to CRUSADE risk categories.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">CI: confidence interval; COPD: chronic obstructive pulmonary disease; IHMB: in-hospital major bleeding; LVEF: left ventricular ejection fraction; OR: unadjusted odds ratio. Data are presented as mean ± standard deviation or as percentage.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No IHMB (n=2766) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">IHMB (n=52) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">OR (95% CI) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age, years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">66±13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">74±11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.01 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.65 (2.05-6.92)<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">67.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">82.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.029 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.31 (1.12-4.76) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Angina \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">39.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">56.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.01 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.13 (1.22-3.72) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Previous bleeding \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.99 (3.87-16.50) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">COPD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">11.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.021 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.58 (1.08-6.15) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.15 (1.91-9.02) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Heart rate, bpm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">76±18 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">88±27 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.01 (3.15-8.03)<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hemoglobin, g/dl \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.8±1.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.1±2.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.005 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.90 (1.06-5.85)<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Femoral access \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">35.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6.10 (3.39-10.97) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">LVEF \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">57±13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">49±12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.15 (3.01-8.57)<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">d</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Enoxaparin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">32.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.002 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.49 (1.38-4.49) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Warfarin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">11.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.034 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.48 (1.04-5.92) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ticagrelor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.028 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.81 (1.48-9.87) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Mortality \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.61 (2.12-10.03) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1922092.png" ] ] ] "notaPie" => array:4 [ 0 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">For each additional 5 years.</p>" ] 1 => array:3 [ "identificador" => "tblfn0020" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0020">For each additional 5 bpm.</p>" ] 2 => array:3 [ "identificador" => "tblfn0025" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0025">For each reduction of 0.5 g/dl.</p>" ] 3 => array:3 [ "identificador" => "tblfn0030" "etiqueta" => "d" "nota" => "<p class="elsevierStyleNotepara" id="npar0030">For each reduction of 5%.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall">Variables associated with in-hospital major bleeding.</p>" ] ] 5 => array:8 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at5" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0120" class="elsevierStyleSimplePara elsevierViewall">CI: confidence interval; OR: adjusted odds ratio.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">OR (95% CI) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.027 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.89 (3.01-7.13) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Heart rate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.047 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.95 (1.87-8.10) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Femoral access \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.004 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.29 (5.01-10.18) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ticagrelor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.027 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.92 (1.89-8.15) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1922093.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0115" class="elsevierStyleSimplePara elsevierViewall">Predictors of in-hospital major bleeding.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:42 [ 0 => array:3 [ "identificador" => "bib0215" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the global registry of acute coronary events risk score versus the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines risk score to predict in-hospital mortality and major bleeding in acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Manzano-Fernández" 1 => "M. Sánchez-Martínez" 2 => "P.J. Flores-Blanco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2015.12.048" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2016" "volumen" => "117" "paginaInicial" => "1047" "paginaFinal" => "1054" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26857164" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0220" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P.G. Steg" 1 => "K. Huber" 2 => "F. Andreotti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehr204" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2011" "volumen" => "32" "paginaInicial" => "1854" "paginaFinal" => "1864" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21715717" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0225" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R. Mehran" 1 => "S.V. Rao" 2 => "D.L. Bhatt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.110.009449" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2011" "volumen" => "123" "paginaInicial" => "2736" "paginaFinal" => "2747" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21670242" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0230" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse impact of bleeding on prognosis in patients with acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.W. Eikelboom" 1 => "S.R. Mehta" 2 => "S.S. Anand" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.106.612812" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2006" "volumen" => "114" "paginaInicial" => "774" "paginaFinal" => "782" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16908769" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0235" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S.V. Rao" 1 => "K. O’Grady" 2 => "K.S. Pieper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2005" "volumen" => "96" "paginaInicial" => "1200" "paginaFinal" => "1206" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0240" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E.A. Amsterdam" 1 => "N.K. Wenger" 2 => "R.G. Brindis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2014.09.017" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2014" "volumen" => "64" "paginaInicial" => "e139" "paginaFinal" => "e228" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25260718" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0245" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Subherwal" 1 => "R.G. Bach" 2 => "A.Y. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.108.828541" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2009" "volumen" => "119" "paginaInicial" => "1873" "paginaFinal" => "1882" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19332461" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0250" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Ariza-Solé" 1 => "G. Sánchez-Elvira" 2 => "J.C. Sánchez-Salado" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.thromres.2013.09.019" "Revista" => array:6 [ "tituloSerie" => "Thromb Res" "fecha" => "2013" "volumen" => "132" "paginaInicial" => "652" "paginaFinal" => "658" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24112751" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0255" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Abu-Assi" 1 => "S. Raposeiras-Roubin" 2 => "P. Lear" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/2048872612453924" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J Acute Cardiovasc Care" "fecha" => "2012" "volumen" => "1" "paginaInicial" => "222" "paginaFinal" => "223" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24062910" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0260" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Roffi" 1 => "C. Patrono" 2 => "J.P. Collet" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehv320" "Revista" => array:7 [ "tituloSerie" => "Eur Heart J" "fecha" => "2016" "volumen" => "37" "paginaInicial" => "267" "paginaFinal" => "315" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26320110" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1130862115001199" "estado" => "S300" "issn" => "11308621" ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0265" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Universal definition of myocardial infarction" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction" "etal" => false "autores" => array:3 [ 0 => "K. Thygesen" 1 => "J.S. Alpert" 2 => "H.D. White" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehm355" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2007" "volumen" => "28" "paginaInicial" => "2525" "paginaFinal" => "2538" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17951287" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0270" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prediction of creatinine clearance from serum creatinine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.W. Cockcroft" 1 => "M.H. Gault" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000180580" "Revista" => array:6 [ "tituloSerie" => "Nephron" "fecha" => "1976" "volumen" => "16" "paginaInicial" => "31" "paginaFinal" => "41" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1244564" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0275" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "The GUSTO investigators" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199309023291001" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1993" "volumen" => "329" "paginaInicial" => "673" "paginaFinal" => "682" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8204123" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0280" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The meaning and use of the area under a receiver operating characteristic (ROC) curve" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.A. Hanley" 1 => "B.J. McNeil" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1148/radiology.143.1.7063747" "Revista" => array:6 [ "tituloSerie" => "Radiology" "fecha" => "1982" "volumen" => "143" "paginaInicial" => "29" "paginaFinal" => "36" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7063747" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0285" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A review of goodness of fit statistic for use in the development of logistic regression models" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Lemeshow" 1 => "D. Hosmer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Epidemiol" "fecha" => "1982" "volumen" => "115" "paginaInicial" => "92" "paginaFinal" => "106" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7055134" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0290" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "K. Fox" 1 => "K. Carruthers" 2 => "G. Steg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehp499" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2010" "volumen" => "31" "paginaInicial" => "667" "paginaFinal" => "675" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20007159" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0295" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "F.A. Spencer" 1 => "M. Moscucci" 2 => "C.B. Granger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.107.694273" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2007" "volumen" => "116" "paginaInicial" => "2793" "paginaFinal" => "2801" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18025530" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0300" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictive ability of bleeding risk scores in the routine clinical practice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Ariza-Solé" 1 => "J. Salazar-Mendiguchía" 2 => "V. Lorente" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur Heart J Acute Cardiovasc Care" "fecha" => "2015" "volumen" => "4" "paginaInicial" => "205" "paginaFinal" => "210" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0305" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P. Amador" 1 => "J.F. Santos" 2 => "S. Gonçalves" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/17482941.2011.567287" "Revista" => array:6 [ "tituloSerie" => "Acute Card Care" "fecha" => "2011" "volumen" => "13" "paginaInicial" => "68" "paginaFinal" => "75" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21517669" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0310" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-ST-elevation acute coronary syndromes in octogenarians: applicability of the GRACE and CRUSADE scores" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Faustino" 1 => "P. Mota" 2 => "J. Silva" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.repc.2014.01.025" "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2014" "volumen" => "33" "paginaInicial" => "617" "paginaFinal" => "627" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25312887" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0315" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of bleeding risk scores in elderly patients with acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Ariza-Solé" 1 => "F. Formiga" 2 => "V. Lorente" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rec.2013.10.008" "Revista" => array:7 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2014" "volumen" => "67" "paginaInicial" => "463" "paginaFinal" => "470" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24863595" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S147444221070106X" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0320" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A risk score to predict bleeding in patients with acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R. Mehran" 1 => "S.J. Pocock" 2 => "E. Nikolsky" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2009.09.076" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2010" "volumen" => "55" "paginaInicial" => "2556" "paginaFinal" => "2566" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20513595" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0325" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Moscucci" 1 => "K.A. Fox" 2 => "C.P. Cannon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2003" "volumen" => "24" "paginaInicial" => "1815" "paginaFinal" => "1823" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14563340" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0330" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Nikolsky" 1 => "R. Mehran" 2 => "G. Dangas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehm194" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2007" "volumen" => "28" "paginaInicial" => "1936" "paginaFinal" => "1945" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17575270" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0335" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ticagrelor versus clopidogrel in patients with acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L. Wallentin" 1 => "R.C. Becker" 2 => "A. Budaj" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0904327" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "361" "paginaInicial" => "1045" "paginaFinal" => "1057" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19717846" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0340" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "X. Flores-Ríos" 1 => "D. Couto-Mallón" 2 => "J. Rodríguez-Garrido" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur Heart J" "fecha" => "2013" "volumen" => "2" "paginaInicial" => "19" "paginaFinal" => "26" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0345" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Valgimigli" 1 => "A. Gagnor" 2 => "P. Calabró" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Lancet" "fecha" => "2015" "volumen" => "385" "paginaInicial" => "2465" "paginaFinal" => "2476" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0350" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P. Vranckx" 1 => "E. Frigoli" 2 => "M. Rothenbühler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehx048" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2017" "volumen" => "38" "paginaInicial" => "1069" "paginaFinal" => "1080" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28329389" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0355" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "F. Feit" 1 => "M.D. Voeltz" 2 => "M.J. Attubato" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2007.06.026" "Revista" => array:5 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2007" "volumen" => "100" "paginaInicial" => "1364" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17950791" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0360" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B.J. Doyle" 1 => "H.H. Ting" 2 => "M.R. Bell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcin.2007.12.006" "Revista" => array:5 [ "tituloSerie" => "JACC Cardiovasc Interv" "fecha" => "2008" "volumen" => "1" "paginaInicial" => "202" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19463301" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0365" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between bleeding events and in-hospital mortality after percutaneous coronary intervention" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.K. Chhatriwalla" 1 => "A.P. Amin" 2 => "K.F. Kennedy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2013.1556" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2013" "volumen" => "309" "paginaInicial" => "1022" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23483177" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673611604029" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0370" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-Elevation Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Sciahbasi" 1 => "C. Pristipino" 2 => "G. Ambrosio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2008.11.049" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2009" "volumen" => "103" "paginaInicial" => "796" "paginaFinal" => "800" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19268734" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0375" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLESTEACS (Radial Versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome) study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Romagnoli" 1 => "G. Biondi-Zoccai" 2 => "A. Sciahbasi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2012.06.017" "Revista" => array:7 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2012" "volumen" => "60" "paginaInicial" => "2481" "paginaFinal" => "2489" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22858390" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0300289614004955" "estado" => "S300" "issn" => "03002896" ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0380" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P. Généreux" 1 => "R. Mehran" 2 => "T. Palmerini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4244/EIJV7I8A144" "Revista" => array:6 [ "tituloSerie" => "EuroIntervention" "fecha" => "2011" "volumen" => "7" "paginaInicial" => "905" "paginaFinal" => "916" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22157475" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0385" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "RIVAL trial group" "etal" => true "autores" => array:3 [ 0 => "S.S. Jolly" 1 => "S. Yusuf" 2 => "J. Cairns" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(11)60404-2" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2011" "volumen" => "377" "paginaInicial" => "1409" "paginaFinal" => "1420" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21470671" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0390" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of fondaparinux and enoxaparin in acute coronary syndromes" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators" "etal" => true "autores" => array:3 [ 0 => "S. Yusuf" 1 => "S.R. Mehta" 2 => "S. Chrolavicius" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "2006" "volumen" => "254" "paginaInicial" => "1464" "paginaFinal" => "1476" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0395" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of ACUITY and CRUSADE scores in predicting major bleeding during acute coronary syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L.C. Correia" 1 => "F. Ferreira" 2 => "F. Kalil" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arq Bras Cardiol" "fecha" => "2015" "volumen" => "105" "paginaInicial" => "20" "paginaFinal" => "27" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0400" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Boersma" 1 => "K.M. Akkerhuis" 2 => "P. Theroux" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1999" "volumen" => "100" "paginaInicial" => "2045" "paginaFinal" => "2048" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10562258" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0405" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bivalirudin during primary PCI in acute myocardial infarction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G.W. Stone" 1 => "B. Witzenbichler" 2 => "G. Guagliumi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0708191" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2008" "volumen" => "358" "paginaInicial" => "2218" "paginaFinal" => "2230" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18499566" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0410" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B. Ibanez" 1 => "S. James" 2 => "S. Agewall" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehx393" "Revista" => array:3 [ "tituloSerie" => "Eur Heart J" "fecha" => "2017" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27141094" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0415" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "g6269" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Bellemain-Appaix" 1 => "M. Kerneis" 2 => "S.A. O’Connor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.g7265" "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2014" "volumen" => "349" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25432524" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0420" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G. Montalescot" 1 => "L. Bolognese" 2 => "D. Dudek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1308075" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2013" "volumen" => "369" "paginaInicial" => "999" "paginaFinal" => "1010" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23991622" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21742049/0000003700000011/v1_201812150634/S2174204918303805/v1_201812150634/en/main.assets" "Apartado" => array:4 [ "identificador" => "9917" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21742049/0000003700000011/v1_201812150634/S2174204918303805/v1_201812150634/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204918303805?idApp=UINPBA00004E" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 21 | 0 | 21 |
2024 October | 154 | 56 | 210 |
2024 September | 114 | 45 | 159 |
2024 August | 118 | 57 | 175 |
2024 July | 196 | 40 | 236 |
2024 June | 112 | 28 | 140 |
2024 May | 108 | 35 | 143 |
2024 April | 79 | 31 | 110 |
2024 March | 148 | 51 | 199 |
2024 February | 102 | 29 | 131 |
2024 January | 125 | 27 | 152 |
2023 December | 73 | 26 | 99 |
2023 November | 99 | 38 | 137 |
2023 October | 119 | 35 | 154 |
2023 September | 73 | 27 | 100 |
2023 August | 131 | 31 | 162 |
2023 July | 129 | 18 | 147 |
2023 June | 134 | 28 | 162 |
2023 May | 168 | 42 | 210 |
2023 April | 186 | 18 | 204 |
2023 March | 199 | 44 | 243 |
2023 February | 217 | 42 | 259 |
2023 January | 122 | 25 | 147 |
2022 December | 153 | 42 | 195 |
2022 November | 206 | 31 | 237 |
2022 October | 236 | 46 | 282 |
2022 September | 145 | 44 | 189 |
2022 August | 148 | 53 | 201 |
2022 July | 194 | 51 | 245 |
2022 June | 148 | 57 | 205 |
2022 May | 133 | 42 | 175 |
2022 April | 131 | 44 | 175 |
2022 March | 161 | 54 | 215 |
2022 February | 144 | 52 | 196 |
2022 January | 163 | 71 | 234 |
2021 December | 106 | 48 | 154 |
2021 November | 140 | 46 | 186 |
2021 October | 157 | 84 | 241 |
2021 September | 125 | 27 | 152 |
2021 August | 119 | 52 | 171 |
2021 July | 132 | 44 | 176 |
2021 June | 143 | 53 | 196 |
2021 May | 132 | 46 | 178 |
2021 April | 280 | 131 | 411 |
2021 March | 245 | 47 | 292 |
2021 February | 206 | 16 | 222 |
2021 January | 192 | 41 | 233 |
2020 December | 195 | 44 | 239 |
2020 November | 177 | 33 | 210 |
2020 October | 139 | 20 | 159 |
2020 September | 179 | 19 | 198 |
2020 August | 121 | 20 | 141 |
2020 July | 141 | 21 | 162 |
2020 June | 139 | 23 | 162 |
2020 May | 156 | 17 | 173 |
2020 April | 155 | 19 | 174 |
2020 March | 138 | 29 | 167 |
2020 February | 175 | 32 | 207 |
2020 January | 130 | 19 | 149 |
2019 December | 78 | 12 | 90 |
2019 November | 100 | 26 | 126 |
2019 October | 121 | 12 | 133 |
2019 September | 119 | 13 | 132 |
2019 August | 84 | 17 | 101 |
2019 July | 96 | 30 | 126 |
2019 June | 65 | 36 | 101 |
2019 May | 63 | 9 | 72 |
2019 April | 60 | 23 | 83 |
2019 March | 14 | 15 | 29 |
2019 February | 23 | 10 | 33 |
2019 January | 22 | 12 | 34 |
2018 December | 27 | 21 | 48 |
2018 November | 4 | 2 | 6 |